Trials / Conditions / Shock, Hemorrhagic

Shock, Hemorrhagic

14 registered clinical trials studyying Shock, Hemorrhagic — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries. NCT07530653	Hospital Departamental de Villavicencio	—
Withdrawn	Empiric Calcium in Massive Transfusion NCT05953376	University of California, Irvine	Phase 3
Recruiting	Trauma Resuscitation With Low-Titer Group O Whole Blood or Products NCT05638581	University of Alabama at Birmingham	Phase 3
Terminated	Feasibility of Evaluating XSTAT Use in the Prehospital Setting NCT04663087	University of Alabama at Birmingham	N/A
Unknown	Usefulness of Capillary Refill Time and Skin Mottling Score to Predict Intensive Care Unit Admission NCT03831022	Hôpital Necker-Enfants Malades	—
Completed	Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Tra NCT03218722	University Hospital, Grenoble	Phase 3
Terminated	A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2) NCT02872428	Dr. Hasan Alam	Phase 1
Completed	Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO) NCT02736812	French Defence Health Service	Phase 3
Withdrawn	Pre-Hospital Use of Plasma for Traumatic Hemorrhage NCT02303964	Virginia Commonwealth University	Phase 2 / Phase 3
Completed	A Study to Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1) NCT01951560	Dr. Hasan Alam	Phase 1
Unknown	Polydatin Injectable (HW6) for Shock Treatment NCT01780129	Neptunus Pharmaceuticals Inc.	Phase 2
Completed	Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients NCT01262196	Sangart	Phase 2
Completed	Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients NCT01004198	Sangart	Phase 2
Completed	Retroperitoneal Packing or Angioembolization for Hemorrhage Control of Pelvic Fractures NCT02535624	Uppsala University	N/A